Epicondylitis is a chronic degenerative condition of tendons at their attachment to the humeral epicondyles. Lateral epicondylitis ("tennis elbow") affects the outer epicondyle, while medial ("golfer's elbow") affects the inner. This is one of the most common elbow conditions affecting up to 3% of the population annually. Despite the names, it relates more to repetitive hand movements at work than to sports. Treatment in Germany includes modern physiotherapy, shockwave therapy, and innovative MIBRAR® therapy for tendon regeneration.
The term "epicondylitis" (epicondyle inflammation) is somewhat misleading — modern research shows the condition is based on degeneration (tendinosis) rather than inflammation, involving collagen fiber destruction without adequate restoration. Lateral epicondylitis is 5–10 times more common than medial. Peak age is 35–55 years, predominantly affecting the dominant arm.
Professional overload from repetitive hand movements (screwdriver, hammer, mouse, scissors, typing) is the most common cause. Sports including tennis (backhand → lateral), golf, and baseball (throwing → medial) are classic triggers. Age-related degeneration reduces tendon regenerative capacity after 35. Single excessive loading from carrying heavy bags or repair work can initiate the condition. Poor ergonomics including incorrect tennis technique and suboptimal desk height contribute.
Lateral epicondylitis causes pain along the outer elbow radiating to the forearm, worsening with wrist extension against resistance and grip activities — difficulty holding a cup or shaking hands, with a tender point on the lateral epicondyle. Medial epicondylitis produces inner elbow pain worsening with wrist flexion and pronation against resistance, potentially combined with ulnar nerve neuropathy (4th–5th finger numbness).
Clinical examination uses provocative tests: Cozen's test (wrist extension against resistance), Mill's test (passive wrist flexion with extended elbow), and chair test (lifting a chair by its back) with 85–95% sensitivity. Ultrasound shows tendon thickening, hypoechogenicity, loss of fibrillar structure, and neovascularization on Power Doppler. MRI evaluates degeneration degree when diagnosis is uncertain. Radiography occasionally shows calcifications or epicondylar osteophytes. EMG excludes ulnar nerve neuropathy in medial epicondylitis.
Effective in 80–90% of patients but requires patience — up to 6–12 months. Eccentric exercises are the gold standard — slow wrist extension with resistance (Tyler program with Thera-Band FlexBar) stimulates collagen remodeling over a 12-week course twice daily. Activity modification reduces provocative movements with ergonomic correction. A forearm orthosis (counterforce brace) unloads the tendon attachment. NSAIDs are used briefly for acute pain — topical application (diclofenac) is more effective than oral. Shockwave therapy (ESWT) has proven effectiveness for chronic epicondylitis in 3–5 sessions. Corticosteroid injection provides quick but short-term effect (4–6 weeks) — long-term it worsens prognosis! German physicians use it cautiously. Physiotherapy includes deep transverse massage (Cyriax), ultrasound, and laser.
Epicondylitis is included in the indications for MIBRAR® technology — ideally suited for tendinopathy treatment. Cortisone provides rapid relief but weakens the tendon and increases tear risk. Standard PRP contains platelet growth factors but low stem cell concentration. MIBRAR® (ARC) contains not only growth factors (CGF method, Medifuge MF 200) but also mesenchymal stem cells from adipose tissue (LIPOGEMS®), plus powerful anti-inflammatory factors. The result: tendon collagen regeneration rather than temporary pain relief.
The procedure involves ARC preparation from blood and subcutaneous fat, targeted microperforations in the tendon degeneration zone under Sono Control Arm™ guidance (0.1 mm precision), and ARC transplantation into the affected tendon. Outpatient, without anesthesia or side effects. Ultrasound follow-up at 8–12 weeks shows restored normal tendon echostructure.
Indicated for conservative treatment failure after 6–12 months (5–10% of patients). Arthroscopic Hohmann procedure detaches the degenerated tendon from the epicondyle and removes pathological tissue, simultaneously inspecting the joint for intra-articular causes (chondromatosis, plicae). Open surgery resects degenerated tissue and reattaches healthy tendon. For medial epicondylitis with neuropathy, ulnar nerve transposition may be added. Success rate is 85–90% with 6–12 week recovery.
| Service | Price, € | Note |
|---|---|---|
| Diagnostics (ultrasound + MRI + exam) | 2,000–3,500 | 1 day |
| Shockwave therapy (3–5 sessions) | 800–2,000 | outpatient |
| MIBRAR® therapy | on request | outpatient |
| Arthroscopic surgery | 5,000–8,000 | outpatient / 1 day |
All treatment prices in Germany.
Germany offers precise ultrasound and MRI diagnostics, MIBRAR® therapy for tendon regeneration without cortisone or side effects, proven shockwave therapy, individual eccentric exercise programs, arthroscopic surgery at specialized clinics, and multilingual assistance. Chronic epicondylitis is progressive tendon degeneration requiring proper treatment — contact us for the optimal program in Germany.
Or send us a message:
